Gene157
GRK3: G protein-coupled receptor kinase 3
Cite this record
ConductScience Library. GRK3: G protein-coupled receptor kinase 3. Genes, record 157. Release gene-search-2026-11-13-0.2.1, 13 Nov 2026. https://conductscience.org/library/genes/157
- Sources
- 13 sources
- Release
- gene-search-2026-11-13-0.2.1
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P35626 | G protein-coupled receptor kinase 3 | 688 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents84
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| US 20260337666 A1 | 2026-10-29 | 29373 | P35626 | Espacenet |
| US 20260227408 A1 | 2026-08-06 | 4911 | P35626 | Espacenet |
| US 20260193644 A1 | 2026-07-09 | 4716 | P35626 | Espacenet |
| US 12577609 B2 | 2026-03-17 | 29373 | P35626 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 36849 | P35626 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 4716 | P35626 | Espacenet |
| EP 4641202 A2 | 2025-10-29 | 4911 | P35626 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 4716 | P35626 | Espacenet |
| US 20250130221 A1 | 2025-04-24 | 17 | P35626 | Espacenet |
| JP 2025062604 A | 2025-04-14 | 3453 | P35626 | Espacenet |
NIH grants932
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | GRK3 papers | Newest fiscal year |
|---|---|---|---|
| R01HL016037 | Molecular Regulation of Cardiovascular 7 TM Receptors | 32 | 2025 |
| R01EY011500 | Structure-function studies of visual arrestin | 11 | 2025 |
| T32DA007278 | Training in Addiction Neuroscience | 6 | 2025 |
| R01MH054137 | Structure and Function of Dopamine Receptors | 4 | 2025 |
| R01DA008863 | Regulation Of Opioid Receptor Signaling by Endogenous Peptides | 3 | 2025 |
| R01DA012864 | Mechanisms and Cellular Function of Opioid Receptor Endocytosis | 3 | 2025 |
| R01GM122798 | Biasing CXCR3 Signaling to Modulate the Inflammatory Response | 3 | 2025 |
| P30CA016086 | Cancer Center Support Grant | 2 | 2025 |
| P30CA056036 | Translational Research in Cancer | 2 | 2025 |
| P50CA058223 | SPORE in Breast Cancer | 2 | 2025 |
Source NIH's project files
Papers915
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Psychological stress and tumor progression: Molecular mechanisms and therapeutic implications (Review). | Oncol Lett | 2026 | 42741309 | PubTator, text mining | PubMed |
| G protein-coupled receptor kinase 3 regulates CCR7 signaling, trafficking, and T cell responses to CCL19 and CCL21. | J Biol Chem | 2026 | 42617740 | PubTator, text mining | PubMed |
| Functional CCR7A-mediated cellular responses are negatively modulated by the splice variant CCR7B. | PLoS One | 2026 | 42550812 | PubTator, text mining | PubMed |
| G protein-coupled receptor kinase 3 couples atypical chemokine receptor 4 independent of G proteins. | Mol Pharmacol | 2026 | 42284892 | PubTator, text mining | PubMed |
Response by Gao et al to Letter Regarding Article, "G Protein-Coupled Receptor Kinase 3 Exacerbates Diabetic Heart Injuries Through Direct Phosphorylation of Cannabinoid Receptor 2 in Humans and Mice". | Circulation | 2026 | 41911351 | PubTator, text mining | PubMed |
| Letter by Wu et al Regarding Article, "G Protein-Coupled Receptor Kinase 3 Exacerbates Diabetic Heart Injuries Through Direct Phosphorylation of Cannabinoid Receptor 2 in Humans and Mice". | Circulation | 2026 | 41911349 | PubTator, text mining | PubMed |
| Parallel CRISPR screens reveal pathways controlling the cell surface levels of the attractant receptor FPR1. | Commun Biol | 2026 | 41882347 | PubTator, text mining | PubMed |
| Mechanistic insights into the therapeutic properties of delta opioid receptor. | Sci Adv | 2026 | 41880505 | PubTator, text mining | PubMed |
| Exploration of driver biomarkers and immune microenvironment in patients with endometriosis: Evidence from RNA-seq and machine learning. | J Reprod Immunol | 2026 | 41830823 | PubTator, text mining | PubMed |
| Fetal and Neonatal Immune Response to Congenital Cytomegalovirus (cCMV) Infection: A Systematically Conducted Scoping Review. | Viruses | 2026 | 41754585 | PubTator, text mining | PubMed |
None in this release
- Drugs
- Trials
Sources 13
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
- USPTO's sequence listingsPublic domain in the US. Source: United States Patent and Trademark Office, www.uspto.gov
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
- USPTO's sequence listingsUSPTO's sequence listings of patents and published applications, from its bulk data files. No license named for the files. USPTO's terms say "most government-produced materials appearing on this website are not subject to copyright restrictions within the United States and are therefore in the public domain", and ask that USPTO be given appropriate acknowledgement ("Source: United States Patent and Trademark Office, www.uspto.gov"). USPTO does not endorse ConductScience or this release. Read on 12 Nov 2026 at https://www.uspto.gov/terms-use-uspto-websites
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
Source: United States Patent and Trademark Office, www.uspto.gov. USPTO does not endorse ConductScience or this database.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/157
GET https://conductscience.org/api/genes/v1/157/patents?page=2